All patients received transdermal estradiol ( @ g/d ) plus oral medroxyprogesterone acetate @ mg/d ( @ d/mo ) for a @-month run-in period before being randomized in a double-blinded fashion to the addition of transdermal T ( @ g/d ) or placebo .